Reyataz
RxNorm concept 382467, brand name (bn).
- RxCUI
- 382467
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/382467 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- atazanavir sulfate (PIN, has precise ingredient)
- atazanavir 200 MG Oral Capsule [Reyataz] (SBD, ingredient of)
- atazanavir Oral Capsule [Reyataz] (SBDF, ingredient of)
- atazanavir 200 MG [Reyataz] (SBDC, ingredient of)
- atazanavir 300 MG [Reyataz] (SBDC, ingredient of)
- atazanavir 300 MG Oral Capsule [Reyataz] (SBD, ingredient of)
- Reyataz Oral Product (SBDG, ingredient of)
- Reyataz Pill (SBDG, ingredient of)
- atazanavir 50 MG [Reyataz] (SBDC, ingredient of)
- atazanavir Oral Powder [Reyataz] (SBDF, ingredient of)
- Reyataz Oral Powder Product (SBDG, ingredient of)
- atazanavir 50 MG Oral Powder [Reyataz] (SBD, ingredient of)
- atazanavir (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 382467 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/382467 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 382467. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.